QIAGEN Cash on Hand 2010-2023 | QGEN

QIAGEN cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • QIAGEN cash on hand for the quarter ending December 31, 2023 was $1.058B, a 25.42% decline year-over-year.
  • QIAGEN cash on hand for 2023 was $1.058B, a 25.42% decline from 2022.
  • QIAGEN cash on hand for 2022 was $1.418B, a 33.13% increase from 2021.
  • QIAGEN cash on hand for 2021 was $1.065B, a 48.94% increase from 2020.
QIAGEN Annual Cash on Hand
(Millions of US $)
2023 $1,058
2022 $1,418
2021 $1,065
2020 $715
2019 $867
2018 $1,496
2017 $1,024
2016 $532
2015 $421
2014 $577
2013 $380
2012 $484
2011 $276
2010 $934
2009 $866
QIAGEN Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $1,058
2023-09-30 $1,016
2023-06-30 $1,332
2023-03-31 $1,287
2022-12-31 $1,418
2022-09-30 $1,887
2022-06-30 $1,311
2022-03-31 $1,230
2021-12-31 $1,065
2021-09-30 $957
2021-06-30 $898
2021-03-31 $792
2020-12-31 $715
2020-09-30 $768
2020-06-30 $899
2020-03-31 $903
2019-12-31 $867
2019-09-30 $804
2019-06-30 $932
2019-03-31 $940
2018-12-31 $1,496
2018-09-30 $921
2018-06-30 $900
2018-03-31 $1,014
2017-12-31 $1,024
2017-09-30 $975
2017-06-30 $609
2017-03-31 $273
2016-12-31 $532
2016-09-30 $464
2016-06-30 $406
2016-03-31 $447
2015-12-31 $421
2015-09-30 $432
2015-06-30 $372
2015-03-31 $401
2014-12-31 $577
2014-09-30 $692
2014-06-30 $655
2014-03-31 $678
2013-12-31 $380
2013-09-30 $356
2013-06-30 $373
2013-03-31 $461
2012-12-31 $484
2012-09-30 $311
2012-06-30 $266
2012-03-31 $275
2011-12-31 $276
2011-09-30 $486
2011-06-30 $953
2011-03-31 $939
2010-12-31 $934
2010-09-30 $887
2010-06-30 $918
2010-03-31 $889
2009-12-31 $866
2009-09-30 $861
2009-06-30 $390
2009-03-31 $337
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.375B $1.965B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.489B 14.44
Vertex Pharmaceuticals (VRTX) United States $102.789B 29.59
Regeneron Pharmaceuticals (REGN) United States $97.763B 23.70
Bristol Myers Squibb (BMY) United States $90.596B 6.08
CSL (CSLLY) Australia $87.140B 0.00
GSK (GSK) United Kingdom $84.784B 10.63
Gilead Sciences (GILD) United States $81.266B 16.20
Moderna (MRNA) United States $40.654B 0.00
Biogen (BIIB) United States $29.478B 13.50
Argenex SE (ARGX) Netherlands $21.906B 0.00
BioNTech SE (BNTX) Germany $20.613B 21.05
Illumina (ILMN) United States $19.278B 139.14
Genmab (GMAB) Denmark $18.157B 23.27
Alnylam Pharmaceuticals (ALNY) United States $18.100B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.508B 60.87
BeiGene (BGNE) Cayman Islands $14.208B 0.00
Sarepta Therapeutics (SRPT) United States $12.039B 0.00
Incyte (INCY) United States $11.491B 19.10
Exact Sciences (EXAS) United States $10.672B 0.00
Bio-Techne Corp (TECH) United States $9.850B 36.64
Repligen (RGEN) United States $9.250B 95.76
Roivant Sciences (ROIV) United Kingdom $8.768B 0.00
Legend Biotech (LEGN) United States $8.080B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Ascendis Pharma (ASND) Denmark $7.973B 0.00
Viking Therapeutics (VKTX) United States $7.590B 0.00
Intra-Cellular Therapies (ITCI) United States $6.983B 0.00
Exelixis (EXEL) United States $6.937B 36.77
Cytokinetics (CYTK) United States $6.777B 0.00
Vaxcyte (PCVX) United States $6.532B 0.00
Apellis Pharmaceuticals (APLS) United States $5.779B 0.00
Blueprint Medicines (BPMC) United States $5.553B 0.00
Halozyme Therapeutics (HALO) United States $4.887B 15.08
CRISPR Therapeutics AG (CRSP) Switzerland $4.561B 0.00
Krystal Biotech (KRYS) United States $4.439B 0.00
Zealand Pharma (ZLDPF) Denmark $4.439B 0.00
Nuvalent (NUVL) United States $4.233B 0.00
Alkermes (ALKS) Ireland $4.135B 21.82
Immunovant (IMVT) United States $4.032B 0.00
Insmed (INSM) United States $3.702B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.609B 0.00
ImmunityBio (IBRX) United States $3.459B 0.00
Biohaven (BHVN) United States $3.401B 0.00
Axsome Therapeutics (AXSM) United States $3.388B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.309B 0.00
SpringWorks Therapeutics (SWTX) United States $3.261B 0.00
Fortrea Holdings (FTRE) United States $3.249B 0.00
Iovance Biotherapeutics (IOVA) United States $3.223B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.025B 0.00
Amicus Therapeutics (FOLD) United States $3.012B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.890B 0.00
IDEAYA Biosciences (IDYA) United States $2.887B 0.00
Arcellx (ACLX) United States $2.738B 0.00
MorphoSys AG (MOR) Germany $2.731B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.699B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.687B 0.00
Merus (MRUS) Netherlands $2.637B 0.00
Certara (CERT) United States $2.611B 56.21
Janux Therapeutics (JANX) United States $2.433B 0.00
CG Oncology (CGON) United States $2.412B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.294B 0.00
Vericel (VCEL) United States $2.199B 0.00
Arvinas (ARVN) United States $2.159B 0.00
Denali Therapeutics (DNLI) United States $2.132B 0.00
Vera Therapeutics (VERA) United States $2.107B 0.00
Guardant Health (GH) United States $2.089B 0.00
Kymera Therapeutics (KYMR) United States $2.046B 0.00
Celldex Therapeutics (CLDX) United States $2.027B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.000B 0.00
Apogee Therapeutics (APGE) United States $1.968B 0.00
Keros Therapeutics (KROS) United States $1.955B 0.00
Geron (GERN) United States $1.947B 0.00
Intellia Therapeutics (NTLA) United States $1.931B 0.00
Avidity Biosciences (RNA) United States $1.900B 0.00
Galapagos (GLPG) Belgium $1.887B 0.00
Sana Biotechnology (SANA) United States $1.874B 0.00
Structure Therapeutics (GPCR) United States $1.816B 0.00
Twist Bioscience (TWST) United States $1.797B 0.00
Beam Therapeutics (BEAM) United States $1.778B 0.00
NeoGenomics (NEO) United States $1.768B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.748B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.674B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.643B 13.65
Myriad Genetics (MYGN) United States $1.627B 0.00
Bavarian Nordic (BVNRY) Denmark $1.621B 5.32
Inhibrx (INBX) United States $1.616B 0.00
Zai Lab (ZLAB) China $1.562B 0.00
Edgewise Therapeutics (EWTX) United States $1.484B 0.00
ADMA Biologics Inc (ADMA) United States $1.470B 0.00
Dynavax Technologies (DVAX) United States $1.462B 0.00
Kura Oncology (KURA) United States $1.447B 0.00
Neumora Therapeutics (NMRA) United States $1.440B 0.00
Protagonist Therapeutics (PTGX) United States $1.437B 0.00
Morphic Holding (MORF) United States $1.400B 0.00
Gyre Therapeutics (GYRE) United States $1.395B 0.00
ANI Pharmaceuticals (ANIP) United States $1.369B 16.83
Arcus Biosciences (RCUS) United States $1.340B 0.00
Akero Therapeutics (AKRO) United States $1.309B 0.00
Ligand Pharmaceuticals (LGND) United States $1.246B 15.43
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.244B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.237B 0.00
Spyre Therapeutics (SYRE) United States $1.174B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.154B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.154B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.146B 0.00
MannKind (MNKD) United States $1.131B 0.00
Belite Bio (BLTE) United States $1.108B 0.00
Prothena (PRTA) Ireland $1.104B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.102B 0.00
Scholar Rock Holding (SRRK) United States $1.087B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.085B 0.00
AbCellera Biologics (ABCL) Canada $1.063B 0.00
Vir Biotechnology (VIR) United States $1.026B 0.00
Abivax SA (ABVX) France $0.991B 0.00
Liquidia Technologies (LQDA) United States $0.940B 0.00
MiMedx (MDXG) United States $0.922B 208.17
Immunome (IMNM) United States $0.851B 0.00
ALX Oncology Holdings (ALXO) United States $0.844B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.832B 0.00
Cullinan Therapeutics (CGEM) United States $0.829B 0.00
Immatics (IMTX) Germany $0.828B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.805B 0.00
Viridian Therapeutics (VRDN) United States $0.797B 0.00
Tyra Biosciences (TYRA) United States $0.794B 0.00
REGENXBIO (RGNX) United States $0.788B 0.00
89BIO (ETNB) United States $0.786B 0.00
Tango Therapeutics (TNGX) United States $0.782B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.780B 0.00
PureTech Health (PRTC) United States $0.742B 0.00
Cytek Biosciences (CTKB) United States $0.737B 0.00
CARGO Therapeutics (CRGX) United States $0.720B 0.00
Pliant Therapeutics (PLRX) United States $0.717B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.704B 0.00
Mesoblast (MESO) Australia $0.702B 0.00
Pharming Group (PHAR) Netherlands $0.701B 0.00
Praxis Precision Medicines (PRAX) United States $0.700B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.693B 0.00
Kyverna Therapeutics (KYTX) United States $0.687B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.677B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.650B 0.00
EnGene Holdings (ENGN) United States $0.642B 0.00
Disc Medicine (IRON) United States $0.640B 0.00
Dianthus Therapeutics (DNTH) United States $0.616B 0.00
Stoke Therapeutics (STOK) United States $0.609B 0.00
Nurix Therapeutics (NRIX) United States $0.608B 0.00
Aerovate Therapeutics (AVTE) United States $0.601B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.599B 0.00
HilleVax (HLVX) United States $0.598B 0.00
Pharming Group (PHGUF) Netherlands $0.591B 0.00
WAVE Life Sciences (WVE) Singapore $0.580B 0.00
Cogent Biosciences (COGT) United States $0.575B 0.00
Northwest Biotherapeutics (NWBO) United States $0.574B 0.00
Zymeworks (ZYME) United States $0.572B 0.00
Nuvation Bio (NUVB) United States $0.571B 0.00
Cabaletta Bio (CABA) United States $0.570B 0.00
Novavax (NVAX) United States $0.553B 0.00
Olema Pharmaceuticals (OLMA) United States $0.550B 0.00
Mineralys Therapeutics (MLYS) United States $0.548B 0.00
GH Research (GHRS) Ireland $0.546B 0.00
Castle Biosciences (CSTL) United States $0.536B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
ArriVent BioPharma (AVBP) United States $0.520B 0.00
CureVac (CVAC) Germany $0.517B 0.00
Oric Pharmaceuticals (ORIC) United States $0.517B 0.00
Prime Medicine (PRME) United States $0.516B 0.00
AnaptysBio (ANAB) United States $0.516B 0.00
Absci (ABSI) United States $0.504B 0.00
Astria Therapeutics (ATXS) United States $0.504B 0.00
Adlai Nortye (ANL) Cayman Islands $0.497B 0.00
Arbutus Biopharma (ABUS) United States $0.488B 0.00
Allogene Therapeutics (ALLO) United States $0.487B 0.00
Oculis Holding AG (OCS) Switzerland $0.484B 0.00
Applied Therapeutics (APLT) United States $0.483B 0.00
Celcuity (CELC) United States $0.480B 0.00
Shattuck Labs (STTK) United States $0.465B 0.00
Avid Bioservices (CDMO) United States $0.465B 0.00
Humacyte (HUMA) United States $0.464B 0.00
Alector (ALEC) United States $0.461B 0.00
IGM Biosciences (IGMS) United States $0.450B 0.00
Fulcrum Therapeutics (FULC) United States $0.443B 0.00
Fate Therapeutics (FATE) United States $0.440B 0.00
Editas Medicine (EDIT) United States $0.429B 0.00
C4 Therapeutics (CCCC) United States $0.428B 0.00
Third Harmonic Bio (THRD) United States $0.426B 0.00
ACELYRIN, INC (SLRN) United States $0.419B 0.00
Entrada Therapeutics (TRDA) United States $0.415B 0.00
Annexon (ANNX) United States $0.413B 0.00
Travere Therapeutics (TVTX) United States $0.410B 0.00
Voyager Therapeutics (VYGR) United States $0.403B 2.40
MaxCyte (MXCT) United States $0.385B 0.00
Neurogene (NGNE) United States $0.384B 0.00
FibroBiologics (FBLG) United States $0.381B 0.00
ITeos Therapeutics (ITOS) United States $0.380B 0.00
Alto Neuroscience (ANRO) United States $0.380B 0.00
Anika Therapeutics (ANIK) United States $0.380B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.379B 0.00
Adaptive Biotechnologies (ADPT) United States $0.379B 0.00
PepGen (PEPG) United States $0.379B 0.00
Replimune (REPL) United States $0.378B 0.00
Biomea Fusion (BMEA) United States $0.376B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.368B 0.00
Amarin (AMRN) Ireland $0.353B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.351B 0.00
Aura Biosciences (AURA) United States $0.350B 0.00
TScan Therapeutics (TCRX) United States $0.349B 0.00
Precigen (PGEN) United States $0.348B 0.00
Mersana Therapeutics (MRSN) United States $0.346B 0.00
Revance Therapeutics (RVNC) United States $0.343B 0.00
Caribou Biosciences (CRBU) United States $0.340B 0.00
Nkarta (NKTX) United States $0.337B 0.00
Tenaya Therapeutics (TNYA) United States $0.331B 0.00
Rani Therapeutics Holdings (RANI) United States $0.329B 0.00
Urogen Pharma (URGN) United States $0.324B 0.00
Solid Biosciences (SLDB) United States $0.323B 0.00
Jasper Therapeutics (JSPR) United States $0.319B 0.00
Atea Pharmaceuticals (AVIR) United States $0.311B 0.00
Ocugen (OCGN) United States $0.304B 0.00
MeiraGTx Holdings (MGTX) United States $0.302B 0.00
Terns Pharmaceuticals (TERN) United States $0.300B 0.00
Kamada (KMDA) Israel $0.299B 22.61
Nautilus Biotechnology (NAUT) United States $0.295B 0.00
XOMA (XOMA) United States $0.295B 0.00
Contineum Therapeutics (CTNM) United States $0.292B 0.00
Ventyx Biosciences (VTYX) United States $0.286B 0.00
Erasca (ERAS) United States $0.285B 0.00
CorMedix Inc (CRMD) United States $0.284B 0.00
Anavex Life Sciences (AVXL) United States $0.278B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.273B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.271B 0.00
Rapt Therapeutics (RAPT) United States $0.271B 0.00
Werewolf Therapeutics (HOWL) United States $0.269B 0.00
Inozyme Pharma (INZY) United States $0.267B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.262B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.258B 89.60
ChromaDex (CDXC) United States $0.255B 0.00
XBiotech (XBIT) United States $0.250B 0.00
Invivyd (IVVD) United States $0.247B 0.00
Renovaro (RENB) United States $0.244B 0.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Puma Biotechnology (PBYI) United States $0.235B 10.61
Verastem (VSTM) United States $0.233B 0.00
Prima BioMed (IMMP) Australia $0.229B 0.00
AC Immune (ACIU) Switzerland $0.226B 0.00
23andMe Holding (ME) United States $0.222B 0.00
2seventy Bio (TSVT) United States $0.220B 0.00
Coherus BioSciences (CHRS) United States $0.219B 0.00
UniQure (QURE) Netherlands $0.217B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Sutro Biopharma (STRO) United States $0.214B 0.00
Design Therapeutics (DSGN) United States $0.212B 0.00
Opthea (OPT) Australia $0.212B 0.00
Ovid Therapeutics (OVID) United States $0.212B 0.00
Compass Therapeutics (CMPX) United States $0.204B 0.00
G1 Therapeutics (GTHX) United States $0.202B 0.00
Lifecore Biomedical (LFCR) United States $0.201B 0.00
Poseida Therapeutics (PSTX) United States $0.198B 0.00
INmune Bio (INMB) United States $0.197B 0.00
Adverum Biotechnologies (ADVM) United States $0.195B 0.00
Innate Pharma S.A (IPHA) France $0.194B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.192B 0.00
X4 Pharmaceuticals (XFOR) United States $0.190B 0.00
Candel Therapeutics (CADL) United States $0.189B 0.00
Akoya Biosciences (AKYA) United States $0.189B 0.00
Codexis (CDXS) United States $0.186B 0.00
Cardiff Oncology (CRDF) United States $0.178B 0.00
Elevation Oncology (ELEV) United States $0.177B 0.00
Trevi Therapeutics (TRVI) United States $0.175B 0.00
Agenus (AGEN) United States $0.174B 0.00
Alimera Sciences (ALIM) United States $0.173B 0.00
GENFIT S.A (GNFT) France $0.172B 0.00
Adocia (ADOCY) France $0.169B 0.00
Kodiak Sciences (KOD) United States $0.167B 0.00
Inventiva S.A (IVA) France $0.166B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.159B 0.00
Greenwich LifeSciences (GLSI) United States $0.159B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.159B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
ScPharmaceuticals (SCPH) United States $0.157B 0.00
Zura Bio (ZURA) United States $0.156B 0.00
CervoMed (CRVO) United States $0.154B 0.00
BioStem Technologies (BSEM) $0.153B 0.00
Gossamer Bio (GOSS) United States $0.152B 0.00
Annovis Bio (ANVS) United States $0.150B 0.00
Adicet Bio (ACET) United States $0.149B 0.00
I-Mab (IMAB) China $0.146B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Cellectis S.A (CLLS) France $0.138B 0.00
Syros Pharmaceuticals (SYRS) United States $0.136B 0.00
DBV Technologies S.A (DBVT) France $0.133B 0.00
Omega Therapeutics (OMGA) United States $0.130B 0.00
VistaGen Therapeutics (VTGN) United States $0.127B 0.00
Sagimet Biosciences (SGMT) United States $0.125B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
PDS Biotechnology (PDSB) United States $0.120B 0.00
Repare Therapeutics (RPTX) Canada $0.117B 0.00
Vor Biopharma (VOR) $0.116B 0.00
Nuvectis Pharma (NVCT) United States $0.116B 0.00
Immunic (IMUX) United States $0.114B 0.00
Seer (SEER) United States $0.113B 0.00
Cartesian Therapeutics (RNAC) United States $0.113B 0.00
Seres Therapeutics (MCRB) United States $0.112B 0.00
CytomX Therapeutics (CTMX) United States $0.108B 0.00
ATyr Pharma (LIFE) United States $0.108B 0.00
TELA Bio (TELA) United States $0.108B 0.00
BioAtla (BCAB) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
Sangamo Therapeutics (SGMO) United States $0.104B 0.00
Rezolute (RZLT) United States $0.104B 0.00
Adagene (ADAG) China $0.104B 0.00
Emergent Biosolutions (EBS) United States $0.102B 0.00
BioHarvest Sciences (CNVCF) Canada $0.102B 0.00
Bluebird Bio (BLUE) United States $0.100B 0.00
Vigil Neuroscience (VIGL) United States $0.097B 0.00
BioXcel Therapeutics (BTAI) United States $0.097B 0.00
DiaMedica Therapeutics (DMAC) United States $0.096B 0.00
IO Biotech (IOBT) Denmark $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.094B 0.00
Elicio Therapeutics (ELTX) United States $0.093B 0.00
Q32 Bio (QTTB) United States $0.092B 0.00
Allakos (ALLK) United States $0.089B 0.00
Genelux (GNLX) United States $0.089B 0.00
BeyondSpring (BYSI) United States $0.088B 0.00
Abeona Therapeutics (ABEO) United States $0.087B 0.00
Curis (CRIS) United States $0.086B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
Aileron Therapeutics (ALRN) United States $0.085B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.084B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
InflaRx (IFRX) Germany $0.082B 0.00
Oncolytics Biotech (ONCY) Canada $0.081B 0.00
Leap Therapeutics (LPTX) United States $0.081B 0.00
Eton Pharmaceuticals (ETON) United States $0.080B 0.00
HOOKIPA Pharma (HOOK) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.86
Cognition Therapeutics (CGTX) United States $0.075B 0.00
Passage Bio (PASG) United States $0.075B 0.00
Gritstone Bio (GRTS) United States $0.075B 0.00
Connect Biopharma Holdings (CNTB) United States $0.075B 0.00
Affimed (AFMD) Germany $0.074B 0.00
YS Biopharma (YS) China $0.074B 0.00
Athira Pharma (ATHA) United States $0.074B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.073B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.072B 0.00
Elutia (ELUT) United States $0.070B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.070B 0.00
Alpha Teknova (TKNO) United States $0.069B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
AN2 Therapeutics (ANTX) United States $0.068B 0.00
Instil Bio (TIL) United States $0.068B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Turnstone Biologics (TSBX) United States $0.067B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Equillium (EQ) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.063B 0.00
Rallybio (RLYB) United States $0.062B 0.00
Aligos Therapeutics (ALGS) United States $0.062B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.061B 0.00
Celularity (CELU) United States $0.059B 0.00
Cidara Therapeutics (CDTX) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Lantern Pharma (LTRN) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
CalciMedica (CALC) United States $0.057B 0.00
LENZ Therapeutics (LENZ) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
HCW Biologics (HCWB) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
Intensity Therapeutics (INTS) United States $0.054B 0.00
AVROBIO (AVRO) United States $0.053B 0.00
Genenta Science S.p.A (GNTA) Italy $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
ARCA Biopharma (ABIO) United States $0.050B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.050B 0.00
Prenetics Global (PRE) Cayman Islands $0.045B 0.00
NKGen Biotech (NKGN) United States $0.045B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
Clene (CLNN) United States $0.045B 0.00
Bolt Biotherapeutics (BOLT) United States $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Ocean Biomedical (OCEA) United States $0.043B 0.00
Immuneering (IMRX) United States $0.042B 0.00
Beyond Air (XAIR) United States $0.042B 0.00
Apollomics (APLM) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Aadi Bioscience (AADI) United States $0.041B 0.00
Carmell (CTCX) United States $0.040B 0.00
Cara Therapeutics (CARA) United States $0.038B 0.00
Ocuphire Pharma (OCUP) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
NextCure (NXTC) United States $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Eyenovia (EYEN) United States $0.034B 0.00
IN8bio (INAB) United States $0.033B 0.00
Fortress Biotech (FBIO) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Theratechnologies (THTX) Canada $0.031B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.018B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
KALA BIO (KALA) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
ABVC BioPharma (ABVC) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Vaxxinity (VAXX) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
Trevena (TRVN) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.30
Artelo Biosciences (ARTL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Biophytis SA (BPTS) France $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00